|
ZDHHC21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65878999999203E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.796800E-04 |
| Normal-vs-Stage2 |
6.183400E-04 |
| Normal-vs-Stage3 |
7.55640000016378E-07 |
| Normal-vs-Stage4 |
4.13150000000417E-05 |
| Stage1-vs-Stage2 |
3.862200E-01 |
| Stage1-vs-Stage3 |
5.057900E-02 |
| Stage1-vs-Stage4 |
1.654410E-01 |
| Stage2-vs-Stage3 |
5.965800E-01 |
| Stage2-vs-Stage4 |
6.946200E-01 |
| Stage3-vs-Stage4 |
9.344200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60257999999303E-05 |
| Normal-vs-AfricanAmerican |
6.212100E-02 |
| Normal-vs-Asian |
1.682520E-03 |
| Caucasian-vs-AfricanAmerican |
3.131200E-01 |
| Caucasian-vs-Asian |
7.209800E-01 |
| AfricanAmerican-vs-Asian |
4.971800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15279999885121E-08 |
| Normal-vs-Female |
2.164300E-04 |
| Male-vs-Female |
1.740060E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.062020E-03 |
| Normal-vs-Age(41-60Yrs) |
1.77738000000094E-05 |
| Normal-vs-Age(61-80Yrs) |
2.35570000000074E-05 |
| Normal-vs-Age(81-100Yrs) |
1.177560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.332980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.255750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.028400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.852800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.840000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.519000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.599600E-03 |
| Classical-VS-Follicular |
2.561800E-01 |
| Classical-VS-Other |
2.217200E-01 |
| Classical-VS-Normal |
2.592900E-04 |
| Tall-VS-Follicular |
2.529600E-01 |
| Tall-VS-Other |
7.519000E-01 |
| Tall-VS-Normal |
1.45590000000251E-06 |
| Follicular-VS-Other |
5.187400E-01 |
| Follicular-VS-Normal |
4.371200E-04 |
| Other-VS-Normal |
1.142070E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55679999997083E-06 |
| Normal-vs-N1 |
1.605580E-04 |
| N0-vs-N1 |
9.712200E-01 |
|
|
